Modulation of 5-fluorouracil by interferon: a review of potential cellular targets.
Horowitz
R
R
Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York 10467, USA.
Schwartz
E L
EL
Wadler
S
S
D000818:Animals; D000970:Antineoplastic Agents / Q000276:immunology / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000276:immunology / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D013936:Thymidine / Q000493:pharmacokinetics; D013939:Thymidine Phosphorylase / Q000378:metabolism; D013940:Thymidylate Synthase / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D007372:Interferons; D013940:Thymidylate Synthase; D013939:Thymidine Phosphorylase; D005472:Fluorouracil; D013936:Thymidine